Human urine does contain stem cells, and they are far more useful than most people would guess. Shed naturally from the lining of the urinary tract, these cells make up a small population within what the body treats as waste, yet they can self-renew and transform into several different tissue types once isolated and grown in the lab.1PubMed Central. Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine Researchers have been studying them seriously for over a decade, and the findings have opened a surprisingly wide range of potential medical applications, from repairing damaged kidneys to modeling rare genetic diseases.
Where These Cells Come From
Urine-derived stem cells (often abbreviated USCs) are not floating around in urine by accident. They originate from various structures along the urinary tract: the twisting tubules of the kidney’s filtering units, the renal pelvis, the ureters, and the bladder lining.1PubMed Central. Urine-Derived Stem Cells: Applications in Regenerative and Predictive Medicine As urine moves through these structures, it picks up cells that have sloughed off the inner walls. Most of those cells are ordinary epithelial cells on their way out, but a fraction of them retain stem-cell-like properties. Because they come from the urinary tract itself, USCs show a natural affinity for urological tissues, which makes them especially interesting for repairing bladder and urethral damage.2Genes & Diseases. Urine-derived stem cells: A novel and versatile progenitor source for cell-based therapy and regenerative medicine
Collecting them is remarkably simple compared to obtaining stem cells from bone marrow, fat tissue, or skin biopsies. A person provides a urine sample, researchers spin it down in a centrifuge to concentrate the cells, and then culture the cells in a growth medium. No needles, no surgery, no anesthesia. The process can be repeated as often as needed, which is a major practical advantage when a patient needs multiple rounds of cells.3PubMed Central. Urine-derived stem cells display homing, incorporation, and regeneration in human organoid and mouse models of acute kidney injury
What Kind of Stem Cells Are They
USCs behave a lot like mesenchymal stem cells, the type found in bone marrow, fat, and other tissues around the body. When researchers test their surface markers, USCs consistently show the molecular signatures typical of mesenchymal cells while lacking the markers associated with blood-forming stem cells.4PubMed Central. Functional characterization of the immunomodulatory properties of human urine-derived stem cells That distinction matters because it tells scientists what USCs can and cannot do: they are well suited for forming connective tissues, muscle, and bone, but they are not a source of new blood cells.
Within any batch of USCs, not all cells are created equal. Some clones show active telomerase, an enzyme linked to long-term self-renewal, while others do not. The telomerase-positive clones tend to grow more robustly and differentiate more effectively into bone, muscle, and bladder-lining cells. In lab tests, those clones expanded to about 62 population doublings, giving researchers a substantial supply of cells from a single starting sample.5Frontiers in Cell and Developmental Biology. Differentiation Capacity of Human Urine-Derived Stem Cells to Retain Telomerase Activity Work from another group found that roughly 9 out of 15 individual USC clones had detectable telomerase and long telomeres, with single clones capable of 60 to 70 doublings.6PubMed. Multipotential differentiation of human urine-derived stem cells: potential for therapeutic applications in urology The cells without telomerase still express many of the same surface markers, but they tend to peter out sooner in culture.7Journal of Stem Cell Research. Urine-Derived Stem Cells With The Capacity for Regeneration and Differentiation: The Importance of Telomerase Activity
Turning Urine Cells Into Pluripotent Stem Cells
USCs on their own are multipotent, meaning they can become several types of tissue but not everything. Researchers can push them further by reprogramming them into induced pluripotent stem cells, which can theoretically become any cell type in the body. A landmark study showed that cells from urine could be reprogrammed into iPSCs using a straightforward, reproducible method, and the resulting cells differentiated extremely well, leading the authors to suggest urine might be a preferred starting material.8PubMed Central. Generation of induced pluripotent stem cells from urine
More recent work has refined the technique using virus-based delivery of reprogramming factors that do not permanently insert themselves into the cell’s DNA, producing what are called integration-free iPSCs. This approach has been validated not only in human urine samples but also in primate urine, and the iPSCs maintained their pluripotency when grown under standardized conditions.9Scientific Reports. A non-invasive method to generate induced pluripotent stem cells from primate urine The ability to go from a urine sample to a fully pluripotent cell line without an invasive biopsy is a significant practical step, especially for pediatric patients and people with conditions that make tissue collection risky.
Repairing Kidneys After Acute Injury
One of the most actively studied applications for USCs is treating acute kidney injury, the kind of sudden kidney damage that can follow severe infections, drug toxicity, or major surgery. In mouse models, intravenous injection of human USCs significantly improved kidney function. Creatinine levels, a standard marker of how well the kidneys filter waste, dropped within 48 hours of treatment and stayed lower throughout the experiment. Blood urea nitrogen, another kidney-function marker, also normalized quickly. The functional recovery matched what researchers saw when using bone-marrow-derived mesenchymal stem cells, suggesting USCs are a competitive alternative.10PubMed Central. Therapeutic potential of urine-derived stem cells in renal regeneration following acute kidney injury: A comparative analysis with mesenchymal stem cells
Separate work in a rat model of cisplatin-induced kidney injury, a common side effect of cancer chemotherapy, found similar results. USCs reduced the inflammatory markers driving tissue damage, dialed down programmed cell death in kidney tissue, and promoted the regrowth of the tubular cells that do the kidney’s filtering work.11PubMed Central. Therapeutic Effects of Human Urine-Derived Stem Cells in a Rat Model of Cisplatin-Induced Acute Kidney Injury In Vivo and In Vitro These findings are still in animal stages, but they point to a scenario where a patient’s own urine sample could one day supply the cells needed to help their kidneys recover.
A 2025 study went further by testing USCs in human kidney organoids, miniature kidney-like structures grown in dishes. The urine-derived cells homed to the damaged areas of the organoids, incorporated into the tissue, and contributed to regeneration, providing early evidence that the repair behavior seen in mice can translate to human tissue contexts.3PubMed Central. Urine-derived stem cells display homing, incorporation, and regeneration in human organoid and mouse models of acute kidney injury
Bladder and Urethral Tissue Engineering
Because USCs originate from the urinary tract, they have a natural edge when it comes to rebuilding bladder and urethral tissue. Lab studies show that USCs can differentiate into both the urothelial cells that line the urinary tract and the smooth-muscle cells that give the bladder its ability to contract and relax. That dual capability is useful for tissue engineering, where you need both layers to reconstruct a functional organ.12PubMed Central. Characterization of urine-derived stem cells obtained from upper urinary tract for use in cell-based urological tissue engineering A 2025 review of the broader field highlighted USCs alongside other mesenchymal stem cells as among the most promising options for bladder and urethral repair, partly because of their immunomodulatory properties and ease of use.13PubMed Central. Current Progress of Tissue Engineering With Stem Cells in Urology Updated Review in 2025
The practical appeal is obvious. A patient who needs bladder reconstruction currently relies on tissue harvested from other parts of their body, typically a segment of intestine, which comes with its own complications. If that patient’s own urine could supply the cells to grow new bladder tissue on a scaffold instead, it would spare them a second surgical site and reduce the risk of mismatch reactions.
Applications Beyond the Urinary Tract
USCs are not limited to urological repairs. Researchers have coaxed them into bone-forming cells and used them to treat skeletal defects. In one approach, human USCs were organized into callus-like structures (mimicking the natural tissue that forms during bone healing) on a silk-based scaffold and then implanted into bone defects in animal models. The implanted organoids accelerated healing beyond what the body’s own repair process achieved.14PubMed. Enhanced Bone Repair using Callus Organoids Derived from Urine-Derived Stem Cells with Silk Fibroin Other groups have explored USCs for skin repair and cartilage regeneration, though these applications remain earlier in development.15Burns & Trauma. Urine-derived stem cells: applications in skin, bone and articular cartilage repair
It turns out that the cells themselves are not the only useful product. USCs secrete tiny membrane-bound packages called exosomes that carry growth factors and signaling molecules. In a rat model of stress urinary incontinence, injecting exosomes derived from USCs (rather than the cells themselves) improved bladder function and repaired damaged pelvic-floor muscle by stimulating muscle cell activation and growth.16PubMed Central. Exosomes secreted by urine-derived stem cells improve stress urinary incontinence by promoting repair of pubococcygeus muscle injury in rats Other studies found that USC-derived exosomes contain factors related to blood-vessel formation and cell survival, and that they could help protect kidneys from the damage caused by type 1 diabetes in rats.17PubMed Central. Exosomes secreted by human urine-derived stem cells could prevent kidney complications from type I diabetes in rats Using exosomes instead of live cells sidesteps some of the concerns about transplanted cells surviving, migrating to the wrong place, or triggering immune responses, which is why this strategy is attracting increasing attention.18PubMed Central. Urine-derived stem/progenitor cells: A focus on their characterization and potential
Modeling Genetic Diseases Without a Biopsy
One of the less obvious but potentially transformative uses of urine-derived cells has nothing to do with putting them back into a patient. Instead, researchers are using USCs as a window into a person’s genetic makeup. Because the cells carry the donor’s full genome, they can serve as patient-specific models for studying genetic disorders. A study found that USCs naturally express genes implicated in over 570 neuromuscular diseases, making them a viable stand-in for hard-to-obtain muscle or nerve cells when researchers want to characterize mutations, identify disease pathways, or screen potential drugs.19Frontiers in Physiology. Urine-Derived Stem Cells Express 571 Neuromuscular Disorders Causing Genes, Making Them a Potential in vitro Model for Rare Genetic Diseases
This matters enormously for rare diseases, where getting a muscle biopsy from a child is invasive and sometimes risky. If a urine sample can give clinicians the same genetic and cellular information, the barrier to diagnosis and research drops sharply. USCs have already been used in diagnostic testing, disease modeling, and drug screening across a range of conditions.20PubMed Central. Urinary Stem Cells as Tools to Study Genetic Disease: Overview of the Literature Researchers have also generated iPSC lines from the urine of individuals with Down syndrome, demonstrating that the approach works for chromosomal conditions and not just single-gene disorders.21Stem Cells Translational Medicine. Generation of Integration-Free Induced Pluripotent Stem Cells from Urine-Derived Cells Isolated from Individuals with Down Syndrome
Safety and the Tumor Question
Whenever stem cells are discussed as a therapy, the worry about tumor formation follows close behind. Stem cells that divide enthusiastically in a dish could, in theory, keep dividing after transplantation in ways the body does not want. Researchers have investigated this directly for USCs. In one study, Klotho-enhanced USCs (modified to boost their regenerative capacity) were tested for long-term safety in animals. When tumors appeared in the highest-dose group, genetic analysis confirmed they were not of human origin, meaning the transplanted cells themselves had not turned cancerous.22PubMed Central. In vivo safety and biodistribution profile of Klotho-enhanced human urine-derived stem cells for clinical application That is encouraging, though any claim of complete safety requires much larger studies and longer follow-up periods. The field is still early enough that no USC therapy has been approved for general clinical use, and caution about tumor risk remains appropriate until human trial data accumulate.
Challenges Standing Between the Lab and the Clinic
For all their promise, USCs face real hurdles before they can become a routine treatment. The yield from any single urine sample is small. Not every sample produces enough viable stem cells, and the proportion of telomerase-positive, highly proliferative clones varies from person to person and even from sample to sample in the same individual. Scaling up production to clinical-grade quantities while keeping the cells in a stem-like state is a challenge that the field is still working through.23PubMed Central. Stem cell mining: urine cells to biobanking
Standardization is another sticking point. Different labs use different collection methods, culture media, and expansion protocols, which makes it hard to compare results across studies. Building biobanks of USCs for future therapeutic use would require agreed-upon standards for quality control, storage, and thawing, none of which are fully settled yet. The regulatory pathway is also murky. Cell therapies in general face rigorous approval processes, and USCs have the added complication of being a relatively new cell source without a long clinical track record.
Ethically, though, urine-derived cells sit in a comfortable spot. Collecting them requires only informed consent and a specimen cup. There are no embryos involved, no surgical procedures, and no tissue destruction. The fact that urine is routinely discarded makes the consent conversation simpler than for most other stem cell sources, though standard research ethics still apply, and institutional review board approval is needed for any study involving human samples.
USCs From Other Species
Humans are not the only animals whose urine yields stem cells. Researchers have successfully isolated and characterized USCs from dogs and rabbits, two species commonly used as preclinical models for urological repair. Canine USCs were isolated from healthy beagles and showed the same mesenchymal-like properties as their human counterparts, opening the door to both veterinary therapies and more rigorous preclinical testing of USC-based treatments.24PubMed Central. Isolation and Characterization of Multipotent Canine Urine-Derived Stem Cells Rabbit USCs have similarly been differentiated into urothelial and smooth-muscle cells, providing an autologous cell source for lower urinary tract tissue engineering experiments in a widely used surgical model.25PubMed. Characterization of rabbit urine-derived stem cells for potential application in lower urinary tract tissue regeneration
The cross-species consistency is itself a useful finding. It suggests that the presence of stem-like cells in urine is not a quirk of human biology but a more general mammalian trait. That makes the underlying biology more robust and gives researchers confidence that animal-model results have at least a reasonable chance of translating to people. It also raises a practical possibility for veterinary medicine: if a dog suffers a bladder injury, its own urine might one day supply the raw material for repair, just as a human patient’s might.